About acquisition of significant shareholding
On October 8, 2018, JSC Olainfarm has received a notification from shareholder Nika Saveljeva on increased material shareholding up till 7.80% from share capital with voting rights, since September 7, 2018.
The announcement of N.Saveljeva attached.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top- quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Member of the Management Board
Phone +371 28698449
Upcoming Life Sciences Events
- May 2019
- Zurich: The Pharma Licensing Negotiation Course
- Zurich: Pharma-Biotech Product & Company Valuation
- Zurich: The Pharmaceutical Out-licensing Course